SCHEMBL286410

SCHEMBL286410

O=C(O)Cc1ccccc1Br

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 2/20 0.61
TDP1 Q9NUW8 1/20 0.53
ALDH1A1 P00352 1/20 0.47
PTGS2 P35354 1/20 0.47
BCAT2 O15382 1/20 0.47
CA12 O43570 2/20 0.46
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
CA9 Q16790 2/20 0.46
FFAR1 O14842 1/20 0.46
FFAR4 Q5NUL3 1/20 0.46
GPR52 Q9Y2T5 1/20 0.46
CXCL8 P10145 4/20 0.46
KDM4E B2RXH2 1/20 0.46
CYP1A2 P05177 1/20 0.46
MAPT P10636 1/20 0.46
TAAR1 Q96RJ0 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30565097 1.00 AKR1B1 (0.61) AKR1B1TDP1ALDH1A1PTGS2BCAT2
SCHEMBL29674787 1.00 AKR1B1 (0.61) AKR1B1TDP1ALDH1A1PTGS2BCAT2
Hydrochloric Acid SCHEMBL2532034 0.98 AKR1B1 (0.59) AKR1B1TDP1ALDH1A1PTGS2BCAT2
Methylene Chloride SCHEMBL28048399 0.94 AKR1B1 (0.55) AKR1B1TDP1ALDH1A1PTGS2BCAT2
SCHEMBL1449282 0.84 CA12 (0.47) ALDH1A1CA12CA1CA2CA9
SCHEMBL1778391 0.84 CA12 (0.47) ALDH1A1CA12CA1CA2CA9
SCHEMBL30359 0.83 AKR1B1 (0.76) AKR1B1TDP1PTGS2BCAT2CXCL8
SCHEMBL29410826 0.83 AKR1B1 (0.76) AKR1B1TDP1PTGS2BCAT2CXCL8
SCHEMBL9064608 0.83 ALDH1A1 (0.45) AKR1B1ALDH1A1CA12CA1CA2
SCHEMBL9064385 0.83 ALDH1A1 (0.45) AKR1B1ALDH1A1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1480 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119371356-B Nuciferine derivative, and preparation method and application thereof 云南中医药大学 2026-05-19 CN claimed
EP-4661890-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS Purdue Research Foundation (US) 2025-12-17 EP claimed
US-20250197356-A1 METHOD FOR SYNTHESIZING NUCIFERINE OR DERIVATIVE THEREOF, DERIVATIVE OF NUCIFERINE AND USE THEREOF HUAQIAO UNIVERSITY (CN) 2025-06-19 US claimed
US-12291531-B2 Matrine α-ketoamine compounds, preparation method therefor and use thereof SHANGHAI XINGYE PHARMACEUTICAL TECHNOLOGY CO., LTD (CN) 2025-05-06 US claimed
CN-115108905-B Method for producing (Z) -trifluoromethaneenol ester by copper-catalyzed regioselective olefination and trifluoromethylation of carboxylic acid 湖南大学 2025-04-08 CN claimed
CN-119751768-A Functionalized polyolefin-based nanoparticle as well as preparation method and application thereof 复旦大学 2025-04-04 CN claimed
CN-119371356-A Nuciferine derivative, and preparation method and application thereof 云南中医药大学 2025-01-28 CN claimed
WO-2024167565-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS PURDUE RESEARCH FOUNDATION (US) 2024-08-15 WO claimed
CN-117903046-A Preparation method of anti-epileptic drug pirenzenenaphthalene 威海海洋职业学院 2024-04-19 CN claimed
CN-117756834-A Synthesis method of 2- (aminocarbonylmethyl) phenylboronic acid pinacol ester 大连双硼医药化工有限公司 2024-03-26 CN claimed
US-6403646-B1 ADMINISTERING PHENYLBUTYRIC ACID OR DERIVATIVES TO TREAT LIVER DISEASE AND EMPHYSEMA CAUSED BY PROTEASE INHIBITOR TYPE Z MUTATION; STIMULATES SECRETION WITHOUT INCREASING SYNTHESIS OF PROTEIN PERLMUTTER DAVID H (US) 2002-06-11 US claimed
EP-0710648-B1 Method for producing oxyindoles KI CHEMICAL INDUSTRY CO LTD (JP) 2002-04-03 EP claimed
EP-1124417-A2 COMPOSITIONS COMPRISING PLANT CELL GROWTH REGULATING COMPOUNDS AND METHODS OF USE THEREOF INVITROGEN CORPORATION (US) 2001-08-22 EP claimed
WO-2000024249-A2 COMPOSITIONS COMPRISING PLANT CELL GROWTH REGULATING COMPOUNDS AND METHODS OF USE THEREOF INVITROGEN CORPORATION (US) 2000-05-04 WO claimed
US-5679799-A Method for producing oxyindoles K-I CHEMICAL INDUSTRY CO., LTD. (JP) 1997-10-21 US claimed
EP-0710648-A1 Method for producing oxyindoles K I CHEMICAL INDUSTRY CO., LTD. (JP) 1996-05-08 EP claimed
EP-0134986-B1 BIOLOGICALLY ACTIVE HEPTAPEPTIDES, AGENTS THEREOF AND THEIR USE FARMITALIA CARLO ERBA S.r.l. (IT) 1989-12-27 EP claimed
EP-0134986-A2 Biologically active heptapeptides, agents thereof and their use FARMITALIA CARLO ERBA S.r.l. (IT) 1985-03-27 EP claimed
US-4307034-A ALKYLATION IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 1981-12-22 US claimed
US-3941814-A Process for obtaining D(-)-and L(+)-α-azidophenylacetic acid DYNAMIT NOBEL AKTIENGESELLSCHAFT (DT) 1976-03-02 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250197356-A1 METHOD FOR SYNTHESIZING NUCIFERINE OR DERIVATIVE THEREOF, DERIVATIVE OF NUCIFERINE AND USE THEREOF NUCB2, NISCH, CYP46A1 AKR1B1 439/4885TDP1 4451/4885ALDH1A1 894/4885
US-12291531-B2 Matrine α-ketoamine compounds, preparation method therefor and use thereof TNF, KLKB1, KMO AKR1B1 217/4885TDP1 1537/4885ALDH1A1 2902/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.